Avoro Capital Advisors LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Hemab Therapeutics Holdings, Inc. 13G COAG · 423494103	COAG	423494103	7.1%	3,298,236	13G	8/14/2026 Event 6/30/2026
Avoro Capital Advisors LLC			4.1%	1,925,150
Avoro Ventures LLC			2.9%	1,373,086
Behzad Aghazadeh			7.1%	3,298,236
Arrowhead Pharmaceuticals, Inc. 13G/A Amendment 3 ARWR · 04280A100	ARWR	04280A100	9.6%	13,823,383	13G/A Amendment 3	8/14/2026 Event 6/30/2026
Avoro Capital Advisors LLC			9.6%	13,823,383
Behzad Aghazadeh			9.6%	13,823,383
Avalo Therapeutics, Inc. 13G/A Amendment 1 AVTX · 05338F306	AVTX	05338F306	4.4%	2,333,333	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Avoro Capital Advisors LLC			4.4%	2,333,333
Behzad Aghazadeh			4.4%	2,333,333
Scribe Therapeutics, Inc. 13D SCTX · 811033109	SCTX	811033109	16.4%	3,088,888	13D	7/30/2026 Event 7/24/2026
Avoro Capital Advisors LLC			13.8%	2,598,973
Avoro Ventures LLC			2.6%	489,915
Aghazadeh Behzad			16.4%	3,088,888
Centessa Pharmaceuticals plc 13G/A Amendment 2 CNTA · 152309100	CNTA	152309100	7.4%	11,430,455	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Avoro Capital Advisors LLC			7.4%	11,430,455
Behzad Aghazadeh			7.4%	11,430,455
Soleno Therapeutics Inc 13G/A Amendment 1 SLNO · 834203309	SLNO	834203309	4.5%	2,300,000	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Avoro Capital Advisors LLC			4.5%	2,300,000
Behzad Aghazadeh			4.5%	2,300,000
Xenon Pharmaceuticals, Inc. 13G/A Amendment 5 XENE · 98420N105	XENE	98420N105	6.3%	5,777,777	13G/A Amendment 5	5/15/2026 Event 3/31/2026
Avoro Capital Advisors LLC			6.3%	5,777,777
Behzad Aghazadeh			6.3%	5,777,777
Damora Therapeutics, Inc. 13G DMRA · 36322Q206	DMRA	36322Q206	6.3%	3,783,000	13G	5/15/2026 Event 3/31/2026
Avoro Capital Advisors LLC			6.3%	3,783,000
Behzad Aghazadeh			6.3%	3,783,000
Avalo Therapeutics, Inc. 13G AVTX · 05338F306	AVTX	05338F306	5.8%	1,410,000	13G	5/15/2026 Event 3/31/2026
Avoro Capital Advisors LLC			5.8%	1,410,000
Behzad Aghazadeh			5.8%	1,410,000
Whitehawk Therapeutics, Inc. 13D/A Amendment 5 WHWK · 00032Q104	WHWK	00032Q104	20.0%	18,292,675	13D/A Amendment 5	5/14/2026 Event 5/12/2026
Avoro Capital Advisors LLC			20.0%	15,893,516
Avoro Ventures LLC			4.1%	2,288,950
Behzad Aghazadeh			20.0%	18,292,675
uniQure N.V. 13G/A Amendment 1 QURE · N90064101	QURE	N90064101	9.9%	6,150,000	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			9.9%	6,150,000
Behzad Aghazadeh			9.9%	6,150,000
Centessa Pharmaceuticals plc 13G/A Amendment 1 CNTA · 152309100	CNTA	152309100	10.0%	14,555,555	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			10.0%	14,555,555
Behzad Aghazadeh			10.0%	14,555,555
Avidity Biosciences, Inc. 13G/A Amendment 1 RNAM · 05370A108	RNAM	05370A108	5.5%	8,515,792	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			5.5%	8,515,792
Behzad Aghazadeh			5.5%	8,515,792
Celcuity Inc. 13G CELC · 15102K100	CELC	15102K100	6.7%	3,111,111	13G	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			6.7%	3,111,111
Behzad Aghazadeh			6.7%	3,111,111
Soleno Therapeutics Inc 13G SLNO · 834203309	SLNO	834203309	5.4%	2,900,000	13G	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			5.4%	2,900,000
Behzad Aghazadeh			5.4%	2,900,000
Definium Therapeutics, Inc. 13G DFTX · 24477V105	DFTX	24477V105	5.1%	5,000,000	13G	2/17/2026 Event 12/31/2025
Avoro Capital Advisors LLC			5.1%	5,000,000
Behzad Aghazadeh			5.1%	5,000,000
Monte Rosa Therapeutics, Inc. 13G/A Amendment 5 GLUE · 61225M102	GLUE	61225M102	0%	0	13G/A Amendment 5	11/14/2025 Event 9/30/2025
Avoro Capital Advisors LLC			0%	0
Behzad Aghazadeh			0%	0
Amicus Therapeutics, Inc. 13G/A Amendment 5 FOLD · 03152W109	FOLD	03152W109	4.9%	15,025,000	13G/A Amendment 5	11/14/2025 Event 9/30/2025
Avoro Capital Advisors LLC			4.9%	15,025,000
Behzad Aghazadeh			4.9%	15,025,000
Centessa Pharmaceuticals plc 13G CNTA · 152309100	CNTA	152309100	8.1%	10,808,080	13G	11/14/2025 Event 9/30/2025
Avoro Capital Advisors LLC			8.1%	10,808,080
Behzad Aghazadeh			8.1%	10,808,080
MoonLake Immunotherapeutics 13G/A Amendment 1 MLTX · 61559X104	MLTX	61559X104	3.2%	2,000,000	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Avoro Capital Advisors LLC			3.2%	2,000,000
Behzad Aghazadeh			3.2%	2,000,000
Structure Therapeutics Inc. 13G GPCR · 86366E106	GPCR	86366E106	9.4%	16,216,665	13G	11/14/2025 Event 9/30/2025
Avoro Capital Advisors LLC			9.4%	16,216,665
Aghazadeh Behzad			9.4%	16,216,665
Blueprint Medicines Corp 13G/A Amendment 1 BPMC · 09627Y109	BPMC	09627Y109	0.6%	375,000	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			0.6%	375,000
Behzad Aghazadeh			0.6%	375,000
Soleno Therapeutics Inc 13G/A Amendment 1 SLNO · 834203309	SLNO	834203309	4.1%	2,050,000	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			4.1%	2,050,000
Behzad Aghazadeh			4.1%	2,050,000
Monte Rosa Therapeutics, Inc. 13G/A Amendment 4 GLUE · 61225M102	GLUE	61225M102	6.1%	3,725,000	13G/A Amendment 4	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			6.1%	3,725,000
Behzad Aghazadeh			6.1%	3,725,000
Arrowhead Pharmaceuticals, Inc. 13G/A Amendment 2 ARWR · 04280A100	ARWR	04280A100	8.3%	11,517,441	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			8.3%	11,517,441
Behzad Aghazadeh			8.3%	11,517,441
Tourmaline Bio, Inc. 13G/A Amendment 1 TRML · 89157D105	TRML	89157D105	10.0%	2,555,555	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			10.0%	2,555,555
Behzad Aghazadeh			10.0%	2,555,555
uniQure N.V. 13G QURE · N90064101	QURE	N90064101	6.6%	3,625,000	13G	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			6.6%	3,625,000
Behzad Aghazadeh			6.6%	3,625,000
MoonLake Immunotherapeutics 13G MLTX · 61559X104	MLTX	61559X104	6.5%	4,150,000	13G	8/14/2025 Event 6/30/2025
Avoro Capital Advisors LLC			6.5%	4,150,000
Behzad Aghazadeh			6.5%	4,150,000
Biocryst Pharmaceuticals Inc 13G/A Amendment 1 BCRX · 09058V103	BCRX	09058V103	4.2%	8,700,000	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Avoro Capital Advisors LLC			4.2%	8,700,000
Behzad Aghazadeh			4.2%	8,700,000
Amicus Therapeutics, Inc. 13G/A Amendment 4 FOLD · 03152W109	FOLD	03152W109	6.7%	20,500,000	13G/A Amendment 4	5/15/2025 Event 3/31/2025
Avoro Capital Advisors LLC			6.7%	20,500,000
Behzad Aghazadeh			6.7%	20,500,000
Blueprint Medicines Corp 13G BPMC · 09627Y109	BPMC	09627Y109	6.0%	3,850,000	13G	5/15/2025 Event 3/31/2025
Avoro Capital Advisors LLC			6.0%	3,850,000
Behzad Aghazadeh			6.0%	3,850,000
Aadi Bioscience, Inc. 13D/A Amendment 4 WHWK · 00032Q104	WHWK	00032Q104	20.0%	11,914,961	13D/A Amendment 4	3/4/2025 Event 2/28/2025
Avoro Capital Advisors LLC			18.0%	9,515,802
Avoro Ventures LLC			4.8%	2,288,950
Behzad Aghazadeh			20.0%	11,914,961
Arrowhead Pharmaceuticals, Inc. 13G/A Amendment 1 ARWR · 04280A100	ARWR	04280A100	9.6%	12,028,552	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Avoro Capital Advisors LLC			9.6%	12,028,552
Behzad Aghazadeh			9.6%	12,028,552
Vera Therapeutics, Inc. 13G/A Amendment 1 VERA · 92337R101	VERA	92337R101	8.9%	5,610,000	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Avoro Capital Advisors LLC			8.9%	5,610,000
Behzad Aghazadeh			8.9%	5,610,000
Monte Rosa Therapeutics, Inc. 13G/A Amendment 3 GLUE · 61225M102	GLUE	61225M102	7.1%	4,345,000	13G/A Amendment 3	2/14/2025 Event 12/31/2024
Avoro Capital Advisors LLC			7.1%	4,345,000
Behzad Aghazadeh			7.1%	4,345,000
Aadi Bioscience, Inc. 13D/A Amendment 3 WHWK · 00032Q104	WHWK	00032Q104	14.5%	3,581,961	13D/A Amendment 3	12/23/2024 Event 12/19/2024
Avoro Capital Advisors LLC			11.6%	2,849,402
Avoro Ventures LLC			2.5%	622,350
Behzad Aghazadeh			14.5%	3,581,961